Evidence map›Paper›PMID 30126085›Full record

ArticleSensors (Basel, Switzerland)2018

Continuous Monitoring of Respiratory Rate in Emergency Admissions: Evaluation of the RespiraSense™ Sensor in Acute Care Compared to the Industry Standard and Gold Standard.

Christian Peter Subbe, Sean Kinsella

Abstract readComparative StudyControlled Clinical Trial
In one paragraph

Article in Sensors (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. A review of the literature on the accuracy, strengths, and limitations of visual, thoracic impedance, and electrocardiographic methods used to measure respiratory rate in hospitalized patients.Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc · 2021
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Clinical validation of a novel accelerometer-based respiratory rate monitor.Journal of clinical monitoring and computing · 2026
    Observational
  5. Observational
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Christian Peter SubbeConsultant Acute, Respiratory & Intensive Care Medicine, Bangor University & Ysbyty Gwynedd, Bangor LL57 2PW, Wales, UK. csubbe@hotmail.com.
Sean KinsellaPMD Solutions, Cork T12 T922, Ireland. sean.kinsella@pmd-solutions.com.ORCID 0000-0003-4489-7334

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Respiratory Rate (RR) is the best marker to indicate deterioration but measurement are often inaccurate. The RespiraSense™ is a non-invasive, wireless, body worn, motion-tolerant and continuous respiratory rate monitor. We aimed to determine whether the performance of RespiraSense™ was equivalent to that of a gold standard measurement technique of capnography and the industry standard of manual counts. RespiraSense™ measures respiratory rate and transmit signals wirelessly to a tablet device. We measured respiratory rate in 24 emergency admissions to an Acute Medical Unit in the UK. Patients were observed for two hours. Manual counts were undertaken every 15 min and compared to measurements with capnography and RespiraSense™. Data from 17 patients admitted as medical emergencies was evaluated. For measurements obtained at rest a mean RR of 19.3 (SD 4.89) for manual measurements compared to mean RR of 20.2 (SD 4.54) for measurements obtained with capnography and mean RR of 19.8 (SD 4.52) with RespiraSense™. At rest, RespiraSense™ has a bias of 0.38 and limits of agreement of 1.0 to 1.8 bpm, when compared to the capnography derived RR. Measurements were within pre-defined limits of error at rest. Continuous measurement of RR with RespiraSense™ in patients admitted as acute emergencies is both feasible and reliable.

Indexed as

Respiratory RateAgedCapnographyCritical CareFemaleHumansMaleMiddle AgedMonitoring, PhysiologicReproducibility of Resultsmonitoringrespiratory ratesensor

Identifiers

PMID30126085
PMCPMC6111745

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.